Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Diseases

  Free Subscription


28.01.2019

2 AJR Am J Roentgenol
1 Am J Gastroenterol
1 Biochem Biophys Res Commun
2 BMC Cancer
1 Cancer Res
4 Dig Dis Sci
1 Eur Radiol
4 Gastroenterology
2 Gut
11 Hepatology
2 Int J Cancer
4 J Gastroenterol Hepatol
10 J Hepatol
6 Lancet Oncol
5 PLoS One
1 Pol J Radiol
1 Proc Natl Acad Sci U S A
9 Transplant Proc


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. VERNUCCIO F, Rosenberg MD, Meyer M, Choudhury KR, et al
    Negative Biopsy of Focal Hepatic Lesions: Decision Tree Model for Patient Management.
    AJR Am J Roentgenol. 2019 Jan 23:1-9. doi: 10.2214/AJR.18.20268.
    PubMed     Text format     Abstract available

  2. SARKAR S, Corwin MT, Olson KA, Stewart SL, et al
    Pilot Study to Diagnose Nonalcoholic Steatohepatitis With Dynamic (18)F-FDG PET.
    AJR Am J Roentgenol. 2019 Jan 23:1-9. doi: 10.2214/AJR.18.20012.
    PubMed     Text format     Abstract available


    Am J Gastroenterol

  3. OKAFOR PN, Nnadi AK, Okoli O, Huang AE, et al
    Same- vs Different-Hospital Readmissions in Patients With Cirrhosis After Hospital Discharge.
    Am J Gastroenterol. 2019 Jan 18. doi: 10.14309/ajg.0000000000000050.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  4. YANG X, Du X, Sun L, Zhao X, et al
    SULT2B1b promotes epithelial-mesenchymal transition through activation of the beta-catenin/MMP7 pathway in hepatocytes.
    Biochem Biophys Res Commun. 2019 Jan 16. pii: S0006-291X(19)30042.
    PubMed     Text format     Abstract available


    BMC Cancer

  5. YANG T, Zhang W, Wang L, Xiao C, et al
    Co-culture of dendritic cells and cytokine-induced killer cells effectively suppresses liver cancer stem cell growth by inhibiting pathways in the immune system.
    BMC Cancer. 2018;18:984.
    PubMed     Text format     Abstract available

  6. SHIGEMATSU Y, Inamura K, Yamamoto N, Mise Y, et al
    Impact of CDX2 expression status on the survival of patients after curative resection for colorectal cancer liver metastasis.
    BMC Cancer. 2018;18:980.
    PubMed     Text format     Abstract available


    Cancer Res

  7. LIU C, Liu L, Chen X, Cheng J, et al
    LSD1 Stimulates Cancer-Associated Fibroblasts to Drive Notch3-Dependent Self-Renewal of Liver Cancer Stem-like Cells.
    Cancer Res. 2018;78:938-949.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  8. THEOCHARIDOU E, Giouleme O, Anastasiadis S, Markopoulou A, et al
    Free Cortisol Is a More Accurate Marker for Adrenal Function and Does Not Correlate with Renal Function in Cirrhosis.
    Dig Dis Sci. 2019 Jan 19. pii: 10.1007/s10620-019-5460.
    PubMed     Text format     Abstract available

  9. ZHI SC, Chen SZ, Li YY, Li JJ, et al
    Rosiglitazone Inhibits Activation of Hepatic Stellate Cells via Up-Regulating Micro-RNA-124-3p to Alleviate Hepatic Fibrosis.
    Dig Dis Sci. 2019 Jan 23. pii: 10.1007/s10620-019-5462.
    PubMed     Text format     Abstract available

  10. TANSEL A, Kramer J, Feng H, El-Serag HB, et al
    Risk Trajectories for Readmission and Death After Cirrhosis-Related Hospitalization.
    Dig Dis Sci. 2019 Jan 23. pii: 10.1007/s10620-019-5459.
    PubMed     Text format     Abstract available

  11. BARRITT AS 4TH, Jiang Y, Schmidt M, Hayashi PH, et al
    Charges for Alcoholic Cirrhosis Exceed All Other Etiologies of Cirrhosis Combined: A National and State Inpatient Survey Analysis.
    Dig Dis Sci. 2019 Jan 23. pii: 10.1007/s10620-019-5471.
    PubMed     Text format     Abstract available


    Eur Radiol

  12. CHEN S, Feng S, Wei J, Liu F, et al
    Pretreatment prediction of immunoscore in hepatocellular cancer: a radiomics-based clinical model based on Gd-EOB-DTPA-enhanced MRI imaging.
    Eur Radiol. 2019 Jan 21. pii: 10.1007/s00330-018-5986.
    PubMed     Text format     Abstract available


    Gastroenterology

  13. SINGAL AG, Rich NE, Mehta N, Branch A, et al
    Direct-Acting Antiviral Therapy not Associated with Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study.
    Gastroenterology. 2019 Jan 17. pii: S0016-5085(19)30057.
    PubMed     Text format     Abstract available

  14. BAJAJ JS, Fagan A, Gavis EA, Kassam Z, et al
    Long-term Outcomes after Fecal Microbiota Transplant in Cirrhosis.
    Gastroenterology. 2019 Jan 18. pii: S0016-5085(19)30093.
    PubMed     Text format    

  15. LAI JC, Rahimi R, Verna EC, Kappus MR, et al
    Frailty Associated With Waitlist Mortality Independent of Ascites and Hepatic Encephalopathy in a Multi-Center Study.
    Gastroenterology. 2019 Jan 17. pii: S0016-5085(19)30058.
    PubMed     Text format     Abstract available

  16. KAPLAN DE, Serper M, Mehta R, Fox R, et al
    Effects of Hypercholesterolemia and Statin Exposure on Survival in a Large National Cohort of Patients With Cirrhosis.
    Gastroenterology. 2019 Jan 17. pii: S0016-5085(19)30053.
    PubMed     Text format     Abstract available


    Gut

  17. CHU H, Duan Y, Yang L, Schnabl B, et al
    Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease.
    Gut. 2019;68:359-370.
    PubMed     Text format     Abstract available

  18. LIN HH, Tseng TC, Kao JH
    Large and middle hepatitis B surface antigen: the lower the better?
    Gut. 2018 Mar 7. pii: gutjnl-2018-316030. doi: 10.1136/gutjnl-2018-316030.
    PubMed     Text format    


    Hepatology

  19. PENG TC
    Role of Sarcopenia in Nonalcoholic Fatty Liver Disease: Definition Is Crucially Important.
    Hepatology. 2018;68:788-789.
    PubMed     Text format    

  20. MAZZAFERRO V, Droz Dit Busset M, Bhoori S
    Alpha-Fetoprotein (AFP) in liver transplantation for HCC: The lower, the better.
    Hepatology. 2018 Feb 9. doi: 10.1002/hep.29835.
    PubMed     Text format    

  21. GRETEN TF
    The ABC of adaptive immunity in liver cancer.
    Hepatology. 2018;68:777-779.
    PubMed     Text format    

  22. ZHENG Y, Qu H, Xiong X, Wang Y, et al
    Deficiency of the mitochondrial glycerol 3-phosphate dehydrogenase contributes to hepatic steatosis.
    Hepatology. 2019 Jan 17. doi: 10.1002/hep.30507.
    PubMed     Text format     Abstract available

  23. CAI J, Zhang XJ, Li H
    The Role of Innate Immune Cells in Nonalcoholic Steatohepatitis.
    Hepatology. 2019 Jan 17. doi: 10.1002/hep.30506.
    PubMed     Text format     Abstract available

  24. HASAN KM, Friedman TC, Shao X, Parveen M, et al
    E-cigarettes and Western Diet: Important Metabolic Risk Factors for Hepatic Diseases.
    Hepatology. 2019 Jan 21. doi: 10.1002/hep.30512.
    PubMed     Text format     Abstract available

  25. PRATT DS
    Hepatology Elsewhere.
    Hepatology. 2019 Jan 23. doi: 10.1002/hep.30517.
    PubMed     Text format     Abstract available

  26. YE X, Li C, Zu X, Lin M, et al
    A Large-Scale Multicenter Study Validates AKR1B10 as a New Prevalent Serum Marker for Detection of Hepatocellular Carcinoma.
    Hepatology. 2019 Jan 23. doi: 10.1002/hep.30519.
    PubMed     Text format     Abstract available

  27. HOFMANN AF, Marschall HU
    Plasma Bile Acid Concentrations in Humans: Suggestions for Presentation in Tabular Form.
    Hepatology. 2018 Mar 31. doi: 10.1002/hep.29909.
    PubMed     Text format    

  28. O'LEARY JG, Rajender Reddy K, Wong F, Garcia-Tsao G, et al
    Reply.
    Hepatology. 2018;68:791.
    PubMed     Text format    

  29. DE MATTOS AZ, de Mattos AA
    Evaluating Prognosis of Patients With Acute-On-Chronic Liver Failure: Is the Simplest Score Good Enough?
    Hepatology. 2018;68:790.
    PubMed     Text format    


    Int J Cancer

  30. WANG Y, Tan PY, Handoko YA, Sekar K, et al
    NUF2 is a valuable prognostic biomarker to predict early recurrence of hepatocellular carcinoma after surgical resection.
    Int J Cancer. 2019 Jan 17. doi: 10.1002/ijc.32134.
    PubMed     Text format     Abstract available

  31. BAO C, Pedersen NL, Yang R, Marseglia A, et al
    Diabetes in midlife and risk of cancer in late life: A nationwide Swedish twin study.
    Int J Cancer. 2018;143:793-800.
    PubMed     Text format     Abstract available


    J Gastroenterol Hepatol

  32. TAKAHASHI K, Ozawa E, Nakao K, Aoki S, et al
    Hepatobiliary and Pancreatic: A procalcitonin-secreting and calcitonin-secreting pancreatic neuroendocrine carcinoma.
    J Gastroenterol Hepatol. 2019 Jan 21. doi: 10.1111/jgh.14568.
    PubMed     Text format    

  33. LOHANA AK, Abid S, Sayani R, Tahir U, et al
    Hepatobiliary and Pancreatic: Bleeding in amyloid liver: A rare presentation of primary liver amyloidosis.
    J Gastroenterol Hepatol. 2019 Jan 21. doi: 10.1111/jgh.14567.
    PubMed     Text format    

  34. KODAMA K, Kawaguchi T, Hyogo H, Nakajima T, et al
    Clinical features of hepatocellular carcinoma in nonalcoholic fatty liver disease patients without advanced fibrosis.
    J Gastroenterol Hepatol. 2019 Jan 22. doi: 10.1111/jgh.14608.
    PubMed     Text format     Abstract available

  35. ZHUGE Y, Liu Y, Xie W, Zou X, et al
    Expert consensus on the clinical management of pyrrolizidine alkaloid induced hepatic sinusoidal obstruction syndrome.
    J Gastroenterol Hepatol. 2019 Jan 22. doi: 10.1111/jgh.14612.
    PubMed     Text format     Abstract available


    J Hepatol

  36. MARASCO G, Colecchia A, Colli A, Ravaioli F, et al
    Reply to correspondence concerning: "Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection".
    J Hepatol. 2019 Jan 17. pii: S0168-8278(18)32645.
    PubMed     Text format    

  37. WANG Q, Xia D, Bai W, Wang E, et al
    Development of a prognostic score for recommended TACE candidates with hepatocellular carcinoma: a multicentre observational study.
    J Hepatol. 2019 Jan 17. pii: S0168-8278(19)30025.
    PubMed     Text format     Abstract available

  38. GANNE-CARRIE N, Nahon P
    Hepatocellular carcinoma in the setting of alcohol-related liver disease.
    J Hepatol. 2019;70:284-293.
    PubMed     Text format     Abstract available

  39. GAO B, Ahmad MF, Nagy LE, Tsukamoto H, et al
    Inflammatory pathways in alcoholic steatohepatitis.
    J Hepatol. 2019;70:249-259.
    PubMed     Text format     Abstract available

  40. BARAHMAN M, Zhang W, Yaffe Harris H, Aiyer A, et al
    Radiation-primed hepatocyte transplantation in murine monogeneic dyslipidemia normalizes cholesterol and prevents atherosclerosis.
    J Hepatol. 2019 Jan 14. pii: S0168-8278(19)30022.
    PubMed     Text format     Abstract available

  41. XU QG, Yuan SX, Tao QF, Yu J, et al
    A novel HBx genotype serves as a preoperative predictor and fails to activate the JAK1/STATs pathway in hepatocellular carcinoma.
    J Hepatol. 2019 Jan 14. pii: S0168-8278(19)30018.
    PubMed     Text format     Abstract available

  42. VAN WETTERE M, Purcell Y, Bruno O, Payance A, et al
    Low specificity of washout to diagnose hepatocellular carcinoma in nodules showing arterial hyperenhancement in patients with Budd-Chiari.
    J Hepatol. 2019 Jan 14. pii: S0168-8278(19)30021.
    PubMed     Text format     Abstract available

  43. PAUMELLE R, Haas J, Hennuyer N, Bauge E, et al
    Hepatic PPARalpha is critical in the metabolic adaptation to sepsis.
    J Hepatol. 2019 Jan 21. pii: S0168-8278(19)30027.
    PubMed     Text format     Abstract available

  44. GWAG T, Meng Z, Sui Y, Helsley RN, et al
    Non-nucleoside reverse transcriptase inhibitor efavirenz activates PXR to induce hypercholesterolemia and hepatic steatosis.
    J Hepatol. 2019 Jan 21. pii: S0168-8278(19)30029.
    PubMed     Text format     Abstract available

  45. GRANCINI V, Trombetta M, Lunati ME, Boselli ML, et al
    Central role of the beta-cell in driving regression of diabetes after liver transplantation in cirrhotic patients.
    J Hepatol. 2019 Jan 21. pii: S0168-8278(19)30028.
    PubMed     Text format     Abstract available


    Lancet Oncol

  46. ABOU-ALFA GK
    Ramucirumab and the controversial role of alpha-fetoprotein in hepatocellular carcinoma.
    Lancet Oncol. 2019 Jan 18. pii: S1470-2045(19)30009.
    PubMed     Text format    

  47. ZHU AX, Kang YK, Yen CJ, Finn RS, et al
    Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased alpha-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Lancet Oncol. 2019 Jan 18. pii: S1470-2045(18)30937.
    PubMed     Text format     Abstract available

  48. KOKUDO T, Kokudo N, Hasegawa K
    Negative phase 3 study of (90)Y microspheres versus sorafenib in HCC.
    Lancet Oncol. 2018;19:e68.
    PubMed     Text format    

  49. LLOVET JM, Finn RS
    Negative phase 3 study of (90)Y microspheres versus sorafenib in HCC.
    Lancet Oncol. 2018;19:e69.
    PubMed     Text format    

  50. GARIN E, Rolland Y, Campillo-Gimenez B, Edeline J, et al
    Negative phase 3 study of (90)Y microspheres versus sorafenib in HCC.
    Lancet Oncol. 2018;19:e70.
    PubMed     Text format    

  51. VILGRAIN V, Pereira H, Dinut A, Chatellier G, et al
    Negative phase 3 study of (90)Y microspheres versus sorafenib in HCC - Authors' reply.
    Lancet Oncol. 2018;19:e71.
    PubMed     Text format    


    PLoS One

  52. SUN S, Hanzawa F, Umeki M, Ikeda S, et al
    Time-restricted feeding suppresses excess sucrose-induced plasma and liver lipid accumulation in rats.
    PLoS One. 2018;13:e0201261.
    PubMed     Text format     Abstract available

  53. SENDI H, Mead I, Wan M, Mehrab-Mohseni M, et al
    miR-122 inhibition in a human liver organoid model leads to liver inflammation, necrosis, steatofibrosis and dysregulated insulin signaling.
    PLoS One. 2018;13:e0200847.
    PubMed     Text format     Abstract available

  54. BOTEON YL, Wallace L, Boteon APCS, Mirza DF, et al
    An effective protocol for pharmacological defatting of primary human hepatocytes which is non-toxic to cholangiocytes or intrahepatic endothelial cells.
    PLoS One. 2018;13:e0201419.
    PubMed     Text format     Abstract available

  55. TANG Y, Blomenkamp KS, Fickert P, Trauner M, et al
    NorUDCA promotes degradation of alpha1-antitrypsin mutant Z protein by inducing autophagy through AMPK/ULK1 pathway.
    PLoS One. 2018;13:e0200897.
    PubMed     Text format     Abstract available

  56. EYRAUD D, Suner L, Dupont A, Bachelot-Loza C, et al
    Evolution of platelet functions in cirrhotic patients undergoing liver transplantation: A prospective exploration over a month.
    PLoS One. 2018;13:e0200364.
    PubMed     Text format     Abstract available


    Pol J Radiol

  57. SAMADI K, Arellano RS
    Microwave ablation of hepatocellular carcinoma metastatic to peritoneum: diagnostic value of hydrodissection.
    Pol J Radiol. 2018;83:e459-e460.
    PubMed     Text format    


    Proc Natl Acad Sci U S A

  58. JIANG P, Sun K, Tong YK, Cheng SH, et al
    Preferred end coordinates and somatic variants as signatures of circulating tumor DNA associated with hepatocellular carcinoma.
    Proc Natl Acad Sci U S A. 2018;115:E10925-E10933.
    PubMed     Text format     Abstract available


    Transplant Proc

  59. VAZQUEZ-MILLAN MA, Otero A, Suarez F
    How Do Hepatologists Gain Access to Liver Transplant Units?
    Transplant Proc. 2018 Jun 28. pii: S0041-1345(18)30838.
    PubMed     Text format     Abstract available

  60. MUNOZ PG, Santiago AM, Bellido CB, Franco CC, et al
    Liver Cirrhosis From Chronic Hypervitaminosis A Resulting in Liver Transplantation: A Case Report.
    Transplant Proc. 2019 Jan 14. pii: S0041-1345(18)30885.
    PubMed     Text format     Abstract available

  61. ANGELICO R, Pietrobattista A, Candusso M, Tomarchio S, et al
    Primary Prophylaxis for Gastrointestinal Bleeding in Children With Biliary Atresia and Portal Hypertension Candidates for Liver Transplant: A Single-Center Experience.
    Transplant Proc. 2018 Jun 28. pii: S0041-1345(18)30849.
    PubMed     Text format     Abstract available

  62. FERNANDEZ IM, Leon Diaz FJ, Sanchez Perez SB, Daga P, et al
    Comparison of 3 Explant-Based Prognostic Models as Predictors of Hepatocellular Carcinoma Recurrence After Liver Transplantation: Analysis of Our Experience.
    Transplant Proc. 2018 Jun 28. pii: S0041-1345(18)30835.
    PubMed     Text format     Abstract available

  63. SERENARI M, Pettinato C, Bonatti C, Zanoni L, et al
    Hepatobiliary Scintigraphy in the Preoperative Evaluation of Potential Living Liver Donors.
    Transplant Proc. 2018 Jun 30. pii: S0041-1345(18)30875.
    PubMed     Text format     Abstract available

  64. PRIETO M, Valdivieso A, Gastaca M, Pijoan JI, et al
    Hepaticojejunostomy in Orthotopic Liver Transplant: A Retrospective Case Control Study.
    Transplant Proc. 2018 Jun 30. pii: S0041-1345(18)30855.
    PubMed     Text format     Abstract available

  65. INSFRAN LAM, Gago FA, Romero PR, Campos PC, et al
    Liver Transplantation for Fulminant Hepatic Failure Due to Heat Stroke: A Case Report.
    Transplant Proc. 2018 Jun 30. pii: S0041-1345(18)30876.
    PubMed     Text format     Abstract available

  66. KAWANO Y, Sanada Y, Urahashi T, Ihara Y, et al
    Transition of Spleen Volume Long After Pediatric Living Donor Liver Transplantation for Biliary Atresia.
    Transplant Proc. 2018;50:2718-2722.
    PubMed     Text format     Abstract available

  67. LOZANO P, Orue-Echabarria MI, Asencio JM, Sharma H, et al
    Donor Risk Index Has an Impact in Intraoperative Measure of Hepatic Artery Flow and in Clearance of Indocyanine Green: An Observational Cohort Study.
    Transplant Proc. 2019 Jan 14. pii: S0041-1345(18)30878.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: